Julie E. Bauman, MD, MPH
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Julie E. Bauman, MD, MPH sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Julie E. Bauman, MD, MPH: 4 sponsored US clinical trials, none currently recruiting.
Julie E. Bauman, MD, MPH sponsors 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 1 completed. 0 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy Subject, with 1 trials.
Upper-quartile sponsor footprint
Julie E. Bauman, MD, MPH sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
4 total, page 1 of 1
Ficlatuzumab, Cisplatin and IMRT in Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT02277184
Broccoli Sprout Extracts in Healthy Volunteers: A Pilot Study of Nrf2 Pathway Modulation in Oral Mucosa
NCT02023931
Cetuximab and Dasatinib in Recurrent Squamous Cell Carcinoma
NCT01488318
Phase II Study of RAD001 Head and Neck Cancer
NCT01051791
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 2 |
Therapeutic Areas
How the Julie E. Bauman, MD, MPH early-phase archive is shaped
4 indexed studies, none listed as recruiting (0% open); 1 completed (25%).
Phase mix: 0 late (III/IV) vs 4 early (I/II) (early-phase heavy).
Top condition: Healthy Subject (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Julie E. Bauman, MD, MPH: archived-pipeline peers nationwide
Peers matched on 4 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Julie E. Bauman, MD, MPH sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 archived trials
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Julie E. Bauman, MD, MPH page
4 registered trials is a research-attention snapshot, not an endorsement of Julie E. Bauman, MD, MPH or any single study.
- None of Julie E. Bauman, MD, MPH's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Healthy Subject is the condition Julie E. Bauman, MD, MPH studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy Subject trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Julie E. Bauman, MD, MPH pipeline card: 4 registered trials from official public datasets.Report a data error.